The future of CRISPR gene editing according to plant scientists

被引:3
|
作者
de Lange, Job [1 ]
Nalley, Lawton Lanier [1 ]
Yang, Wei [1 ]
Shew, Aaron [1 ]
de Steur, Hans [2 ]
机构
[1] Univ Arkansas, Dept Agr Econ, Fayetteville, AR 72701 USA
[2] Univ Ghent, Dept Agr Econ, Ghent, Belgium
关键词
GENETICALLY-MODIFIED FOOD; CLIMATE-CHANGE; BREEDING TECHNOLOGIES; SECURITY; CROPS; METAANALYSIS; OPPORTUNITY; ACCEPTANCE; DEMAND; RISKS;
D O I
10.1016/j.isci.2022.105012
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study surveyed 669 plant scientists globally to elicit how (which outcomes of gene editing), where (which continent) and what (which crops) are most likely to benefit from CRISPR research and if there is a consensus about specific barriers to commercial adoption in agriculture. Further, we disaggregated public and private plant scientists to see if there was heterogeneity in their views of the future of CRISPR research. Our findings suggest that maize and soybeans are anticipated to benefit the most from CRISPR technology with fungus and virus resistance the most common vehicle for its implementation. Across the board, plant scientists viewed consumer perception/knowledge gap to be the most impeding barrier of CRISPR adoption. Although CRISPR has been hailed as a technology that can help alleviate food insecurity and improve agricultural sustainability, our study has shown that plant scientists believe there are some large concerns about the consumer perceptions of CRISPR.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
    Si-Wei Wang
    Chao Gao
    Yi-Min Zheng
    Li Yi
    Jia-Cheng Lu
    Xiao-Yong Huang
    Jia-Bin Cai
    Peng-Fei Zhang
    Yue-Hong Cui
    Ai-Wu Ke
    Molecular Cancer, 21
  • [32] Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
    Wang, Si-Wei
    Gao, Chao
    Zheng, Yi-Min
    Yi, Li
    Lu, Jia-Cheng
    Huang, Xiao-Yong
    Cai, Jia-Bin
    Zhang, Peng-Fei
    Cui, Yue-Hong
    Ke, Ai-Wu
    MOLECULAR CANCER, 2022, 21 (01)
  • [33] From gene editing to genome engineering: restructuring plant chromosomes via CRISPR/Cas
    Carla Schmidt
    Patrick Schindele
    Holger Puchta
    aBIOTECH, 2020, 1 : 21 - 31
  • [34] From gene editing to genome engineering: restructuring plant chromosomes via CRISPR/Cas
    Schmidt, Carla
    Schindele, Patrick
    Puchta, Holger
    ABIOTECH, 2020, 1 (01) : 21 - 31
  • [35] Genome editing (CRISPR/Cas9) in plant disease management: challenges and future prospects
    Das, Kallol
    Ayim, Benjamin Yaw
    Borodynko-Filas, Natasza
    Das, Srijan Chandra
    Aminuzzaman, F. M.
    JOURNAL OF PLANT PROTECTION RESEARCH, 2023, 63 (02) : 159 - 172
  • [36] A CRISPR FUTURE FOR GENE-EDITING REGULATION: A PROPOSAL FOR AN UPDATED BIOTECHNOLOGY REGULATORY SYSTEM IN AN ERA OF HUMAN GENOMIC EDITING
    Tomlinson, Tracey
    FORDHAM LAW REVIEW, 2018, 87 (01) : 437 - 483
  • [37] The trust game CRISPR for human germline editing unsettles scientists and society
    Braun, Matthias
    Meacham, Darian
    EMBO REPORTS, 2019, 20 (02)
  • [38] CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool
    Xu, MengMeng
    CELL AND BIOSCIENCE, 2020, 10 (01):
  • [39] CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool
    MengMeng Xu
    Cell & Bioscience, 10
  • [40] CRISPR/CAS9 GENE EDITING
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, : 26 - 27